Publication May 14, 2019 What Is the Role of C-Reactive Protein and Fecal Calprotectin in Evaluating Crohn’s Disease Activity? Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 Advances in Therapeutic Drug Monitoring for Small-Molecule and Biologic Therapies in Inflammatory Bowel Disease Christopher Ma, Niels Vande Casteele, Vipul Jairath Read Now
Publication May 14, 2019 Update on C-Reactive Protein and Fecal Calprotectin: Are They Accurate Measures of Disease Activity in Crohn’s Disease? Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 Systematic Review With Meta-Analysis: Efficacy and Safety of Oral Janus Kinase Inhibitors for Inflammatory Bowel Disease Brian Feagan, Christopher Ma, Niels Vande Casteele, Vipul Jairath Read Now
Publication May 14, 2019 IL12/23 or Selective IL23 Inhibition for the Management of Moderate-To-Severe Crohn’s Disease? Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 Identifying Outcomes in Clinical Trials of Fistulizing Crohn’s Disease for the Development of a Core Outcome Set Brian Feagan, Christopher Ma, Vipul Jairath Read Now
